's ROA from the second quarter of 2026 to the second quarter of 2017 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is 's ROA in the second quarter of 2026?
achieved a return on average assets (ROA) of 20.63 % in its second quarter of 2026, this is above SSRI's average return on assets of 0%.
assets over the 12 months ending in its second quarter of 2026 are valued at $1,754 million

ROA has improved compared to 15.99% in the third quarter of 2021, due to net income growth.

However, within the sector achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the third quarter of 2021 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2017) IV. Quarter
Y / Y Total Assets Change	-25.97 %	-27.26 %	-	-	-
Y / Y Net Income Change	29.34 %	-	-	-	-
Net Income (TTM) in million	362	341	277	199	71
Return On Assets (TTM)	20.63 %	15.99 %	12.48 %	10 %	4.05 %
SSRI's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	4,312	898	906	901	5,824
Seq. Total Assets Change	379.97 %	-0.81 %	0.48 %	-84.52 %	371.6 %
Seq. Net Income Change	44.03 %	-17.5 %	-38.96 %	78.34 %	-

SSRI's 5 Years Annual ROA >> Back to SSRI Management Effectiveness >> Compare SSRI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Assets Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
's Assets	$ 4,312 million	SSRI's Balance sheet
's Income	$ 92 million	Quarterly SSRI's Income Statement
SSRI's Income by Division		See SSRI's Income by Division

Annual Return On Assets	(Dec 31 2020) FY 2020	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017	FY	FY
Y / Y Total Assets Change	268.25 %	-	-	-	-
Total Assets in million	5,602	1,521	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	157	0	71	0	0
Annual Return On Assets	2.81 %	-0 %	-	-	-

SSRI's 5 Years Annual ROA >> Back to SSRI Management Effectiveness >> Compare SSRI ROA to its Competitors

Comment on SSRI's ROA in the fiscal year ending 2020

In the fiscal year 2020 ROA improved to 2.81 % compared to prior year, due to annual net income growth of % to $157.16 million, while value of 's overall assets grew just by 268.25 % to $5,601.56 million, compared to $5,601.56 a year before.

More Return On Assets Ratios
SSRI's' Return on Assets at Yahoo Finance
Industry Return On Assets Trends and Statistics
Sector Roa Statistics
Roa Trends for overall market
SSRI's Roa Ratio versus Industry, Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SSRI's Competitors
Subscribers only: Roa for 's Suppliers
Subscribers only: Return On Assets for SSRI's Customers

You may also want to know
SSRI's Roi	SSRI's Inventory Turnover Ratio	SSRI's Growth Rates	SSRI's Dividend Comparisons
	SSRI's Profitability Ratios	SSRI's Asset Turnover Ratio	SSRI's Dividend Growth
SSRI's Roe	SSRI's Valuation Ratios	SSRI's Financial Strength Ratios	SSRI's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Sector	ROA
Gladstone Investment Corporationde	13.83 %
Chicago Atlantic Bdc Inc	9.14 %
Hercules Capital Inc	8.26 %
Main Street Capital Corporation	7.94 %
Msc Income Fund Inc	7.16 %
Trinity Capital Inc	5.60 %
Fidus Investment Corporation	5.47 %
Gladstone Capital Corp	5.34 %
Capital Southwest Corporation	5.26 %
Green Thumb Industries Inc.	4.91 %
Triplepoint Venture Growth Bdc Corp	4.88 %

Date modified: 2026-10-15T05:23:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.